Clinical Trials Logo

Clinical Trial Summary

Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted to find a therapy that reduces pain, with non-steroidal anti-inflammatory drugs such as oral ibuprofen the current mainstay. Our study attempts to determine which of the following NSAIDS is best at reducing pain associated with the HSG procedure: oral ibuprofen versus oral ketorolac .


Clinical Trial Description

Describe step-by-step how the study will be conducted from beginning to end 1. After IRB approval, the research pharmacist will provide motrin and ketorolac in identical packets labeled 1-88, after receiving the randomization strategy/number set from the research monitor. 2. REI physician on the protocol will screen patient for inclusion/exclusion from study at new patient consult or at future follow up visit when need for HSG is decided. 3. If patient pt screens eligible, discuss study. If elects participation then consent patient and randomize to group. 4. At time of scheduling HSG, patient will need to remind nursing that they are in HSG study. Nursing should also have the list of patients to reference when scheduling HSGs. Patients in the study will need to check in at the REI clinic 70 minutes prior to HSG in order to take their meds 60 minutes prior to scheduled procedure time. At same visit, REI RN will perform urine pregnancy test as previously scheduled. a. meds will be kept in a locked cabinet in the REI research office in opaque sealed envelopes. 5. Patient will then go check into Radiology for their HSG. 6. HSG will be performed per standard clinical protocol. The HSG will be performed by REI physicians and OB/GYN residents (who are rotating on REI), which are the current standard of practice. 7. A nurse or provider associated with the study will need to be at the HSG for the sole purpose of study assistance. The provider performing the HSG, the study personnel recording pain levels, and the fluro tech will not be aware of the type of pre-procedural medication the patient received. The nurse or provider of study personnel will do the following: 1. time the procedure from placement of speculum through deflation of catheter balloon and removal of catheter. Record time in seconds (can write mins:seconds and then convert later). 2. record who performed the procedure, if a tenaculum had to be used, and if an attending had to take over the procedure 3. help patient record pain scale marks on the VAS sheet at the designated time periods. 7. For clarity- there will be at least three providers at each HSG for study enrolled patients. 1. A provider who does the HSG 2. A fluoro technician to capture fluoro images for teh HSG 3. A study affialitied person to record pain scores for patient as above 8. At the conclusion of study recruitment, the blinded researchers will gain access to the subject ID's cohort status (ibuprofen vs ketorolac), and study analysis will be undertaken. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05190341
Study type Interventional
Source Madigan Army Medical Center
Contact Bruce Pier, MD
Phone 253-968-3276
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date January 31, 2022
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT03177538 - Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders Phase 4
Completed NCT03638856 - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy N/A
Completed NCT04052464 - The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
Active, not recruiting NCT03349905 - Deferred Versus Fresh Embryo Transfers N/A
Recruiting NCT05076981 - Progesterone Levels During Ovulation and Luteal Phase
Completed NCT04096027 - Cabergoline Before or After Oocyte Collection for Follicular Resolution Phase 4
Not yet recruiting NCT04753736 - Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC N/A
Not yet recruiting NCT04537078 - Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders Phase 3
Terminated NCT01933633 - Improved Fertility After Exercise in Overweight/Obese Women N/A
Terminated NCT01202643 - Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF Phase 1/Phase 2
Completed NCT01202656 - Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization) Phase 1/Phase 2
Completed NCT01408615 - A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165) N/A
Not yet recruiting NCT03910582 - Personalized FET in RIF Patients With Displaced Dating N/A
Recruiting NCT05130125 - Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
Recruiting NCT05084274 - Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program N/A
Recruiting NCT04438759 - Clinical Efficacy of Virtual Reality During Office Hysteroscopy and Endometrial Biopsy in Subfertility N/A
Enrolling by invitation NCT03592849 - The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring N/A
Recruiting NCT05076032 - Phase II Clinical Trial to Evaluate the Ongoing Pregnancy Rate With OXO-001 in IVF/ICSI With Donor Oocytes. Phase 2
Not yet recruiting NCT04962789 - Endometrial Compaction in Assissted Reproduction
Recruiting NCT04518189 - Transdermal Lidocaine for Pain Control During Hysterosalpingography N/A